1. Home
  2. DRD vs TYRA Comparison

DRD vs TYRA Comparison

Compare DRD & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$24.26

Market Cap

2.5B

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$28.28

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
TYRA
Founded
1895
2018
Country
South Africa
United States
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DRD
TYRA
Price
$24.26
$28.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$32.63
$47.50
AVG Volume (30 Days)
247.8K
807.7K
Earning Date
08-19-2026
05-06-2026
Dividend Yield
2.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.23
N/A
Revenue Next Year
$30.12
N/A
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.08
$8.98
52 Week High
$39.37
$40.65

Technical Indicators

Market Signals
Indicator
DRD
TYRA
Relative Strength Index (RSI) 43.97 42.75
Support Level $23.26 $27.40
Resistance Level $32.74 $31.57
Average True Range (ATR) 0.95 1.98
MACD 0.16 0.26
Stochastic Oscillator 53.47 42.12

Price Performance

Historical Comparison
DRD
TYRA

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: